Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Meningioma microenvironment harbors a rich immune landscape that evolves with biological state.
Journal: Neuro-oncology
Published: April 27, 2025
Vascular STING activation facilitates NK cell anti-tumor immunity in small cell lung cancer.
Journal: Cancer cell
Published: September 05, 2024
Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer.
Journal: Cancer research communications
Published: July 10, 2024
STING activation promotes robust immune response and NK cell-mediated tumor regression in glioblastoma models.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 05, 2022
The germline factor DDX4 contributes to the chemoresistance of small cell lung cancer cells.
Journal: Communications biology
Published: May 24, 2022
MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung Cancer.
Journal: Cancer research
Published: March 08, 2022
Activation of Tumor-Cell STING Primes NK-Cell Therapy.
Journal: Cancer immunology research
Published: January 07, 2022
MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer.
Journal: Cancer cell
Published: August 20, 2021
Plasticity in the Absence of NOTCH Uncovers a RUNX2-Dependent Pathway in Small Cell Lung Cancer.
Journal: Cancer research
Published: June 22, 2021
KRAS G12C inhibition and innate immune targeting.
Journal: Expert opinion on therapeutic targets
Published: March 11, 2021
Surgical and Peri-Operative Considerations for Brain Metastases.
Journal: Frontiers in oncology
Published: February 01, 2021
Last Updated: 09/26/2026